Toxic Shock Syndrome: Characterization of Human Immune Responses to TSST-1 and Evidence for Sensitivity Thresholds

Toxicological Sciences

Volumn 134, Issue 1, 2013, Pages 49-63

  Kimber, Ian ^a   Nookala, Suba ^b,c   Davis, Catherine C ^d   Gerberick, G Frank ^d   Tucker, Heidi ^d   Foertsch, Leslie M ^d   Dearman, Rebecca J ^a   Parsonnet, Jeffrey ^e   Goering, Richard V ^f   Modern, Paul ^e   Donnellen, Meghan ^f   Morel, Jorge ^d   Kotb, Malak ^b,g  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d PROCTER AND GAMBLE COMPANY   (United States)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^f CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cytokines menstrual toxic shock syndrome; HLA haplotypes; Superantigens; T cell proliferation

Indexed keywords

AGGLUTININ; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; INTERLEUKIN 2; PHYTOHEMMAGLUTININ; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG; BACTERIAL TOXIN; BACTERIUM ANTIBODY; ENTEROTOXIN; ENTEROTOXIN F, STAPHYLOCOCCAL; HLA D ANTIGEN; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; SUPERANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BLOOD SAMPLING; CELL POPULATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; FEMALE; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; TOXIC SHOCK SYNDROME; ADOLESCENT; B LYMPHOCYTE; BIOSYNTHESIS; BLOOD; CELL CULTURE; COHORT ANALYSIS; DIFFERENTIAL THRESHOLD; DOSE RESPONSE; DRUG EFFECTS; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MENSTRUATION; MICROBIOLOGY; MONONUCLEAR CELL; SEPTIC SHOCK; STAPHYLOCOCCUS INFECTION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BACTERIAL TOXINS; CELL PROLIFERATION; CELLS, CULTURED; COHORT STUDIES; DIFFERENTIAL THRESHOLD; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENTEROTOXINS; FEMALE; HAPLOTYPES; HLA-D ANTIGENS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MENSTRUATION; MITOGENS; PHYTOHEMAGGLUTININS; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84880258669     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft099     Document Type: Article

References (30)

1. Choi, Y. W., Kotzin, B., Herron, L., Callahan, J., Marrack, P., and Kappler, J. (1989). Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad. Sci. U. S. A. 86, 8941-8945.
2. Davis, C. C., Kremer, M. J., Schlievert, P. M., and Squier, C. A. (2003). Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: Permeability characteristics, toxin distribution, and tissue damage. Am. J. Obstet. Gynecol. 189, 1785-1791.
3. Davis, J. P., Chesney, P. J., Wand, P. J., and LaVenture, M. (1980). Toxic-shock syndrome: Epidemiologic features, recurrence, risk factors, and prevention. N. Engl. J. Med. 303, 1429-1435.
4. Faulkner, L., Cooper, A., Fantino, C., Altmann, D. M., and Sriskandan, S. (2005). The mechanism of superantigen-mediated toxic shock: Not a simple Th1 cytokine storm. J. Immunol. 175, 6870-6877. Kansal, R., Davis, C., Hansmann, M., Seymour, J., Parsonnet, J., Modern, P.,
5. Gilbert, S., and Kotb, M. (2007). Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome. J. Clin. Immunol. 27, 327-338.
6. Kotb, M. (2004). Genetics of susceptibility to infectious diseases. ASM News 70, 457-463.
7. Kotb, M., Norrby-Teglund, A., McGeer, A., El-Sherbini, H., Dorak, M. T., Khurshid, A., Green, K., Peeples, J., Wade, J., Thomson, G., et al. (2002). An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat. Med. 8, 1398-1404.
8. Kotb, M., Norrby-Teglund, A., McGeer, A., Green, K., and Low, D. E. (2003). Association of human leukocyte antigen with outcomes of infectious diseases: The streptococcal experience. Scand. J. Infect. Dis. 35, 665-669.
9. Latham, R. H., Haslam, B. T., Dewitt, C., Skolnick, M., and Smith, C. B. (1983). Histocompatibility leukocyte antigens in patients with toxic-shock syndrome. J. Infect. Dis. 147, 783.
10. Marrack, P., and Kappler, J. (1990). The staphylococcal enterotoxins and their relatives. Science 248, 705-711.
11. Matsuda, Y., Kato, H., Yamada, R., Okano, H., Ohta, H., Imanishi, K., Kikuchi, K., Totsuka, K., and Uchiyama, T. (2003). Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor VBeta2-positive T cells. Emerg. Infect. Dis. 9, 387-389.
12. McCormick, J. K., Yarwood, J. M., and Schlievert, P. M. (2001). Toxic shock syndrome and bacterial superantigens: An update. Annu. Rev. Microbiol. 55, 77-104.
13. Melkus, M. W., Estes, J. D., Padgett-Thomas, A., Gatlin, J., Denton, P. W., Othieno, F. A., Wege, A. K., Haase, A. T., and Garcia, J. V. (2006). Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 12, 1316-1322.
14. Monday, S. R., and Bohach, G. A. (1999). Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates. J. Clin. Microbiol. 37, 3411-3414.
15. Nooh, M. M., Aziz, R. K., Kotb, M., Eroshkin, A., Chuang, W. J., Proft, T., and Kansal, R. (2006). Streptococcal mitogenic exotoxin, SmeZ, is the most susceptible M1T1 streptococcal superantigen to degradation by the streptococcal cysteine protease, SpeB. J. Biol. Chem. 281, 35281-35288.
16. Nooh, M. M., El-Gengehi, N., Kansal, R., David, C. S., and Kotb, M. (2007). HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis. J. Immunol. 178, 3076-3083.
17. Nooh, M. M., Nookala, S., Kansal, R., and Kotb, M. (2011). Individual genetic variations directly effect polarization of cytokine responses to superantigens associated with streptococcal sepsis: Implications for customized patient care. J. Immunol. 186, 3156-3163.
18. Osterholm, M. T., Davis, J. P., Gibson, R. W., Mandel, J. S., Wintermeyer, L. A., Helms, C. M., Forfang, J. C., Rondeau, J., and Vergeront, J. M. (1982). Tri-state toxic-state syndrome study. I. Epidemiologic findings. J. Infect. Dis. 145, 431-440.
19. Parsonnet, J., Goering, R. V., Hansmann, M. A., Jones, M. B., Ohtagaki, K., Davis, C. C., and Totsuka, K. (2008). Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women. J. Clin. Microbiol. 46, 2731-2738.
20. Parsonnet, J., Hansmann, M. A., Delaney, M. L., Modern, P. A., Dubois, A. M., Wieland-Alter, W., Wissemann, K. W., Wild, J. E., Jones, M. B., Seymour, J. L., et al. (2005). Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J. Clin. Microbiol. 43, 4628-4634.
21. Parsonnet, J., Hansmann, M. A., Seymour, J. L., Delaney, M. L., DuBois, A. M., Modern, P. A., Jones, M. B., Wild, J. E., and Onderdonk, A. B. (2010). Persistence survey of Toxic Shock Syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women. BMC Infect. Dis. 10, 249.
22. Parsonnet, J., Mills, J. T., Gillis, Z. A., and Pier, G. B. (1985). Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1. J. Clin. Microbiol. 22, 26-31.
23. Pontzer, C. H., Russell, J. K., and Johnson, H. M. (1991). Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules. Proc. Natl. Acad. Sci. U. S. A. 88, 125-128.
24. Rasigade, J. P., Thomas, D., Perpoint, T., Peyramond, D., Chidiac, C., Etienne, J., Vandenesch, F., Lina, G., and Ferry, T. (2011). T-cell response to superantigen restimulation during menstrual toxic shock syndrome. FEMS Immunol. Med. Microbiol. 62, 368-371.
25. Schlievert, P. M., and Bohach, G. A. (2007). Staphylococcal and streptococcal superantigens: An update. In Superantigens: Molecular Basis for Their Role in Human Diseases (M. Kotb and J. D. Fraser, Eds.), pp. 221-326. ASM Press, Washington, DC.
26. Schlievert, P. M., Bohach, G. A., Hovde, C. J., Kreiswirth, B. N., and Novick, R. P. (1990). Molecular studies of toxic shock syndrome-associated staphylococcal and streptococcal toxins. In Molecular Biology of Staphylococci, 9th ed. (R. P. Novick, Ed.), pp 313-326. New York, VCH.
27. Schlievert, P. M., Shands, K. N., Dan, B. B., Schmid, G. P., and Nishimura, R. D. (1981). Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 143, 509-516.
28. Squier, C. A., Mantz, M. J., Schlievert, P. M., and Davis, C. C. (2008). Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J. Pharm. Sci. 97, 9-21.
29. Todd, J., Fishaut, M., Kapral, F., and Welch, T. (1978). Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet 2, 1116-1118.
30. White, J., Herman, A., Pullen, A. M., Kubo, R., Kappler, J. W., and Marrack, P. (1989). The V beta-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56, 27-35.